[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.169.191. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

January 25, 2017
Brief Report

Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter DefibrillatorInsights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry

Abstract Full Text
JAMA Cardiol. Published online January 25, 2017. doi:10.1001/jamacardio.2016.5388

This cohort study identifies patient, clinician, and hospital characteristics associated with cardiac resynchronization therapy defibrillator use and determine the extent of hospital-level variation in this use among guideline-eligible patients undergoing implantable cardioverter defibrillator placement.

Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab

Abstract Full Text
JAMA Cardiol. Published online January 25, 2017. doi:10.1001/jamacardio.2016.5395

This study of pooled data from patients in 4 randomized clinical trials characterizes variability in proprotein convertase subtilisin kexin type 9 (PCSK9) levels and determines whether the reduction in low-density lipoprotein cholesterol level achieved with evolocumab differs based on PCSK9 levels.

Review

Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral AnticoagulantsA Review

Abstract Full Text
JAMA Cardiol. Published online January 25, 2017. doi:10.1001/jamacardio.2016.5224

This review explores the epidemiology and pathophysiology of the nexus of atrial fibrillation and type 2 diabetes to provide an evidence-based update of therapy options for patients with both conditions.

JAMA Cardiology Patient Page

Statins and the Prevention of Heart Disease

Abstract Full Text
free access
JAMA Cardiol. Published online January 25, 2017. doi:10.1001/jamacardio.2016.4320
January 18, 2017
Editorial

The TWENTE Trial in PerspectiveStents and Stent Trials in Evolution

Abstract Full Text
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.5208
Original Investigation

Disaggregation of Cause-Specific Cardiovascular Disease Mortality Among Hispanic Subgroups

Abstract Full Text
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.4653

This population-based cohort study disaggregates mortality data from the National Center for Health Statistics for different types of cardiovascular disease among the 3 largest US Hispanic subgroups, Mexicans, Puerto Ricans, and Cubans.

Five-Year Outcome After Implantation of Zotarolimus- and Everolimus-Eluting Stents in Randomized Trial Participants and Nonenrolled Eligible PatientsA Secondary Analysis of a Randomized Clinical Trial

Abstract Full Text
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.5190

This secondary analysis of a randomized clinical trial evaluates the 5-year outcomes of zotarolimus-eluting stents vs everolimus-eluting stents to treat randomized participants and nonenrolled eligible patients with non–ST-segment elevation acute coronary syndromes.

Invited Commentary

Challenges in Assessing Cardiovascular Mortality Among Hispanic/Latino Groups in the United States

Abstract Full Text
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.5018
JAMA Cardiology Clinical Challenge

A Woman in Emotional Distress With Chest Pain

Abstract Full Text
has multimedia
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.4230

A woman in her late 50s with a history of multiple sclerosis, without traditional atherosclerosis risk factors and not taking medications, presented to the emergency department after having 30 minutes of pain in her left shoulder and vague chest pressure that had already resolved. What would you do next?

Editor's Note

The Importance of Long-term Follow-up Within Randomized Clinical Trials of Cardiovascular Devices

Abstract Full Text
free access
JAMA Cardiol. Published online January 18, 2017. doi:10.1001/jamacardio.2016.5209
January 11, 2017
Original Investigation

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Abstract Full Text
open access
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5034

This cohort study assesses the structural and electrical progression of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients over time.

Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5131

This cohort study uses data from the National Inpatient Sample database to examine rates of in-hospital reperfusion and outcomes among renal transplant recipients hospitalized with ST-segment elevation myocardial infarction.

Invited Commentary

Quantifying Disease Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Key to Advancing Therapy

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5035

Challenges of Assessing Common Problems Presenting in Uncommon High-Risk Patient Populations

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5207
Review

The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial FibrillationA Review

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5167

This review assesses the benefits of cardiovascular implantable electronic devices for the detection and treatment of subclinical atrial fibrillation among patients enrolled in clinical studies.

Comment & Response

Statin Eligibility Under American and European Cholesterol Guidelines

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5080

Statin Eligibility Under American and European Cholesterol Guidelines—Reply

Abstract Full Text
JAMA Cardiol. Published online January 11, 2017. doi:10.1001/jamacardio.2016.5081
January 4, 2017
Original Investigation

Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5139

This longitudinal study characterizes myocardial infarctions, including type, identifies causes of type 2 myocardial infarctions, and compares demographic and clinical characteristics among human immunodeficiency virus–infected individuals with type 1 vs type 2 myocardial infarctions.

Prognostic Implications of Raphe in Bicuspid Aortic Valve Anatomy

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5228

This study investigates the association between bicuspid aortic valve morphologic findings (raphe vs nonraphe) and the degree of valve dysfunction, presence of aortopathy, and prognosis (including need for aortic valve surgery, aortic dissection, and all-cause mortality).

Research Letter

Discontinuation of Warfarin Therapy for Patients With Atrial FibrillationThe Michigan Anticoagulation Quality Improvement Initiative Experience

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5041

This study finds that most patients undergoing warfarin therapy for atrial fibrillation discontinue it within the first year, particularly those who have scheduled electrical cardioversion or radiofrequency ablation.

Rate of Statin Prescription in Younger Patients With Severe Dyslipidemia

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5162

This study examines statin prescription rates among patients with dyslipidemia.

Comment & Response

Effect of Iron Levels on Women After Premature or Early-Onset Menopause

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5082

Effect of Iron Levels on Women After Premature or Early-Onset Menopause

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5083

Effect of Iron Levels on Women After Premature or Early-Onset Menopause—Reply

Abstract Full Text
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5084
Correction

Error in Author Affiliation and Results

Abstract Full Text
free access
JAMA Cardiol. Published online January 4, 2017. doi:10.1001/jamacardio.2016.5663
×